74 Questions
Which chronic bowel disorder is associated with an abnormal immune response in the intestinal mucosa due to dietary proteins like gluten?
Coeliac disease
What condition should be referred to a specialist center if confirmed to be refractory?
Coeliac disease
Which gastrointestinal disorder is characterized by chronic inflammation of the small intestine and malabsorption of nutrients?
Inflammatory bowel disease
What autoimmune condition is associated with gluten present in wheat, barley, and rye?
Coeliac disease
Which chronic bowel disorder is often treated with prednisolone as an initial management option?
Diverticular disease and diverticulitis
Why are enteric-coated and modified-release preparations unsuitable for patients with short bowel syndrome?
They may not release the active ingredient properly in patients with short bowel syndrome.
What should prescribers consider before prescribing liquid formulations to patients with short bowel syndrome?
Osmolarity, excipient content, and required volume
Why is the small intestine considered the most important site of drug absorption?
Due to its large surface area and high blood flow
What factor is affected by the removal of a larger amount of the small intestine?
Drug absorption
Why are hyperosmolar liquids and some excipients (like sorbitol) considered unsuitable for patients with short bowel syndrome?
They can lead to fluid loss in these patients.
Which medication is recommended for the treatment of acute attack of mild to moderate ulcerative colitis affecting the rectosigmoid region by rectum?
PENTASA® Suppositories
What is the recommended daily dose for ASACOL® Suppositories for the treatment of acute attack of mild to moderate ulcerative colitis and maintenance of remission?
1 g daily
For the maintenance of remission of Crohn’s ileo-colitis, what is the maximum recommended daily dosage of MEZAVANT® XL?
4 g daily in 2–3 divided doses
What is the treatment regimen for PENTASA® Retention Enema for the maintenance of remission of mild to moderate ulcerative colitis?
1 g daily
Which medication is advised for the treatment of mild to moderate ulcerative colitis, acute attack, both by rectum and by mouth?
PENTASA® Tablets
What is the recommended direction for administration of PLENVU® according to the manufacturer?
Contents of single sachet for Dose 1 to be mixed with 500 mL of water and taken over 30 minutes
Which electrolyte is present in higher amounts in Dose 2 of PLENVU® compared to Dose 1?
Sodium (Na+)
In patients with significant renal impairment, what does the manufacturer advise regarding monitoring requirements?
Consider monitoring baseline and post-treatment electrolytes, renal function, and ECG
For how long should one pair of sachets (A+B) of MOVIPREP® be taken according to the manufacturer's recommendation?
Over 1-2 hours
What is the primary purpose of taking an additional liter of clear fluid during MOVIPREP® treatment?
To prevent dehydration
What is the recommended daily dosage of ASACOL MR tablets for an adult during an acute attack of mild to moderate ulcerative colitis?
2.4 g
For maintenance of remission of ulcerative colitis and Crohn’s ileo-colitis, what is the appropriate daily dosage range of ASACOL MR tablets for adults?
2.4 g - 4.8 g
At what dose should ASACOL MR tablets be administered to adolescents aged 12-17 years during an acute attack of mild to moderate ulcerative colitis?
800 mg 3 times a day
What is the maximum daily dosage of ASACOL MR tablets for adults during an acute attack of mild to moderate ulcerative colitis?
4.8 g
When treating ulcerative colitis, what is the lowest recommended daily dosage of ASACOL MR tablets for adults?
800 mg
What is the recommended method for reducing abdominal pain when taking the preparation discussed in the text?
Taking the preparation more slowly
What side effect is considered uncommon when using the preparation mentioned in the text?
Dehydration
In patients with renal impairment, what is advised regarding the usage of the preparation?
Use cautiously in mild to moderate impairment, avoid in severe impairment
What is the manufacturer's recommendation for reconstituting one sachet of the preparation?
Reconstitute with 200 mL of hot water and cool for approx. 30 minutes before drinking
What is an important monitoring requirement before starting treatment with the preparation?
Renal function measurement
What is the maintenance dose for adults recommended for Crohn's disease under expert supervision?
108 mg every 2 weeks
In case of no response observed after the initial dose for intravenous infusion, what additional dose may be given 10 weeks after the initial dose?
300 mg
What is the first subcutaneous dose that should be administered in place of the next scheduled intravenous dose for adults with Crohn's disease?
300 mg
If treatment is interrupted or response decreases, what action is recommended regarding dosing frequency according to the provided text?
Increase dosing frequency
What is a contraindication mentioned in the text for using the medication?
Severe active infection
After how many weeks of no response following the initial dose should the treatment be reviewed according to the guidelines provided?
14 weeks
For intravenous infusion, what is the initial dose recommended for adults?
300 mg
What should be done if no response is observed after the initial subcutaneous injection?
Administer another 300 mg dose
What is a characteristic feature of coeliac disease?
Malabsorption of nutrients due to gluten activation of abnormal immune response
Which chronic bowel disorder is associated with inflammation of the small intestine and malabsorption of nutrients?
Inflammatory bowel disease
What autoimmune condition is triggered by dietary proteins found in wheat, barley, and rye?
Coeliac disease
Which gastrointestinal disorder is associated with chronic inflammation and affects the small intestine primarily?
Diverticular disease and diverticulitis
What is a common characteristic of chronic bowel disorders like coeliac disease, inflammatory bowel disease, and irritable bowel syndrome?
Activation of abnormal immune response in the intestinal mucosa
Why are enteric-coated and modified-release preparations considered unsuitable for patients with short bowel syndrome?
They may not provide sufficient release of the active ingredient in these patients.
What should prescribers consider before prescribing liquid formulations to patients with short bowel syndrome?
The osmolarity, excipient content, and required volume of the liquid.
What factor is negatively impacted by the removal of a larger amount of the small intestine?
Drug absorption in the remaining intestine.
Why should hyperosmolar liquids and some excipients like sorbitol be avoided in patients with short bowel syndrome?
They lead to increased fluid loss in individuals with short bowel syndrome.
When prescribing for short bowel syndrome, why are quick dissolution dosage forms like soluble tablets recommended?
They ensure rapid absorption of medications despite shortened intestines.
What is the recommended volume of clear fluid to be taken after each dose of PLENVU® according to the manufacturer's advice?
500 mL
Which electrolyte is present in a higher amount in one pair of sachets (A+B) of MOVIPREP® compared to Dose 1 of PLENVU®?
Sodium (Na+)
In debilitated patients or those at risk of electrolyte imbalance, what should be considered before prescribing the medication based on the manufacturer’s instructions?
Monitoring baseline and post-treatment electrolytes, renal function, and ECG
What is the recommended reconstitution volume for one sachet of Dose 1 of PLENVU® according to the prescribing and dispensing information provided?
500 mL
For MOVIPREP®, how much clear fluid should be taken during treatment along with reconstituting one pair of sachets (A+B) up to 1 litre with water?
500 mL
What is the recommended daily maintenance dose for PENTASA® Suppositories in adults for ulcerative proctitis?
2 g once daily
For the treatment of mild to moderate ulcerative colitis affecting the descending colon, which medication and administration route is recommended according to the text?
ASACOL® Suppositories by rectum
What is the appropriate dosage range for MEZAVANT® XL in adults during an acute attack of mild to moderate ulcerative colitis?
Up to 4 g once daily
What is the recommended daily dosage range of ASACOL MR tablets for adults during the maintenance of remission of ulcerative colitis and Crohn’s ileo-colitis?
1-2.4 g daily
Which medication is advised for the maintenance of remission of Crohn’s ileo-colitis at the maximum recommended daily dosage range?
MEZAVANT® XL
In treating mild to moderate ulcerative colitis, acute attack, what is the daily dosage of ASACOL MR tablets for adolescents aged 12-17 years?
400-800 mg 3 times a day
What is the recommended treatment regimen for OCTASA® in adults with mild to moderate ulcerative colitis during an acute attack?
By mouth, 2.4-4.8 g once daily
What is the recommended method for reducing abdominal pain when taking the preparation?
Taking the preparation more slowly
What is the maximum daily recommended dosage of ASACOL MR tablets for adults in the treatment of mild to moderate ulcerative colitis, acute attack?
4.8 g daily
What is the advised action for prescribers before prescribing liquid formulations to patients with short bowel syndrome?
Consider the sorbitol content of the liquid
When treating Crohn’s ileo-colitis with ASACOL MR tablets, what is the appropriate daily dosage range for adults?
2.4-4.8 g daily
In patients with significant renal impairment, what does the manufacturer advise regarding monitoring requirements?
Intensive renal function monitoring before treatment
In the treatment of mild to moderate ulcerative colitis, acute attack, what is the daily dosage of ASACOL MR 800MG tablets for adults?
2.4-3.6 g daily
What is a common side effect when taking the preparation mentioned in the text?
Gastrointestinal discomfort
For patients at risk of fluid and electrolyte disturbances, what is the recommended action regarding renal function monitoring before starting treatment?
Measure renal function before starting treatment
What is the dosing regimen for adults receiving the medication by subcutaneous injection for maintenance of Crohn’s disease under expert supervision?
108 mg every 2 weeks
What is the recommended action if no response is observed within 14 weeks of the initial dose for adults receiving the medication by intravenous infusion?
Review treatment regimen
What is the adult maintenance dose for Crohn's disease under expert supervision following at least 2 intravenous infusions of the medication?
108 mg every 2 weeks
What is the first subcutaneous dose that should be administered in place of the next scheduled intravenous dose for adults with Crohn's disease?
108 mg every 2 weeks
If treatment is interrupted or response decreases, what action is recommended regarding dosing frequency for adults receiving the medication by subcutaneous injection?
Increase dosing frequency
In what timeframe should treatment be reviewed if no response is observed within 10 weeks of the initial dose for adults receiving the medication by subcutaneous injection?
14 weeks
Study Notes
- Diverticular disease and diverticulitis are chronic bowel disorders discussed in the text.
- Coeliac disease is an autoimmune condition related to chronic inflammation of the small intestine triggered by gluten in wheat, barley, and rye.
- The small intestine's large surface area and high blood flow are critical for drug absorption.
- Patients with short bowel syndrome may have issues with drug absorption, particularly with enteric-coated and modified-release preparations.
- Liquid formulations may be more suitable for patients with short bowel syndrome to avoid fluid loss from hyperosmolar liquids.
- Various drugs are used for short bowel syndrome, such as Cimetidine.
- The text provides detailed information on dosages, administration, and monitoring requirements for medications like PLENVU and MOVIPREP in patients with renal impairment.
- Different treatment options for mild to moderate ulcerative colitis are outlined, including oral medications, enemas, suppositories, and tablets.
- Side effects of bowel cleansing preparations can include gastrointestinal discomfort, dehydration, electrolyte imbalance, and dizziness.
- Caution is advised in pregnant and breastfeeding individuals, as well as those with renal impairment, when using certain medications.
Test your knowledge on the treatment of patients with fluid and electrolyte disturbances, including cautions, interactions, side-effects, and considerations during pregnancy. Learn about maintaining adequate hydration and managing common side effects.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
